05 August 2025
05 August 2025
色界吧 by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.
The generics specialist will acquire Just 鈥� Evotec Biologics鈥� biosimilar development and manufacturing plant for $300m.
The immunisation programme aims to reduce rising gonorrhoea rates and address antibiotic-resistant strains.
The initiative will support more than 40 innovations targeting five critical and chronically underfunded areas.
For investors looking for stability and innovation, APAC-based biotech companies in Singapore, South Korea and Japan may be of interest.
Agios entered a distribution agreement with NewBridge in 2024, focusing on regulatory filings and commercialisation.
Atombeat expedites drug discovery using its Hermite software and RiDYMO platform.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
